Results 81 to 90 of about 3,743 (224)

Effectiveness of nephroprotective therapy in children with chronic pyelonephritis in the follow-up observation

Zdorovʹe Rebenka, 2018
Background. Timely correction of hemodynamic disorders in children with chronic pyelonephritis is a component of nephroprotection. Аngiotensin-converting enzyme inhibitors (ACEI) are the basis of renoprotective therapy.
L.I. Vakulenko
doaj   +1 more source

SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects

Medicina, 2019
The burden of diabetic kidney disease (DKD) has increased worldwide in the last two decades. Besides the growth of diabetic population, the main contributors to this phenomenon are the absence of novel nephroprotective drugs and the limited efficacy of those currently available, that is, the inhibitors of renin-angiotensin system.
GAROFALO, Carlo, Borrelli S., Liberti M. E., Andreucci M., Conte G., Minutolo R., Provenzano M., De Nicola L.   +7 more
openaire   +3 more sources

Gentamicin affects the bioenergetics of isolated mitochondria and collapses the mitochondrial membrane potential in cochlear sensory hair cells [PDF]

, 2019
Aminoglycoside antibiotics are widely prescribed to treat a variety of serious bacterial infections. They are extremely useful clinical tools, but have adverse side effects such as oto- and nephrotoxicity.
Abuelezz, Alharazneh, Anthony L. Moore, Bendirdjian, Bendirdjian, Chen, Clerici, Corné J. Kros, Dehne, Ding, Eltahawy, Esterberg, Esterberg, Esterberg, Felix, Forge, Gonzalez, Gray, Gray, Guy P. Richardson, Hailey, He, Hirose, Hobbie, Jensen-Smith, Kluckova, Knight, Kornguth, Krumschnabel, Lash, Lesniak, Long, Lotz, Luke Young, Marcotti, Margulis, Medja, Mingeot-Leclercq, Molly O’Reilly, Nagai, Nerissa K. Kirkwood, Oliveira, Olszewska, O’Sullivan, Prezant, Rahn, Rizzi, Rohlena, Sahu, Schacht, Selimoglu, Servais, Sha, Simmons, Simmons, Skinner, Steyger, Walker, Wargo, Weinberg, Xie, Yang, Åkerman   +62 more
core   +1 more source

ARB I olmesartan interruption in cardiovascular and cardiorenal continuum: antihypertensive and nephroprotective effects (part 1)

КардиоСоматика, 2014
The article provides an overview of the efficacy and tolerability of one of the representatives of the class angiotensin receptor blockers II - olmesartan medoxomil (Kardosal).
M. G Bubnova
doaj  

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile

Медицинский совет, 2018
This article discusses clinicopharmacological niches of fosinopril, one of the most popular ACE inhibitors in daily outpatient practice. The authors cover aspects, where fosinopril has advantages over other ACE inhibitors and angiotensin II receptor ...
G. N. Gorokhovskaya, A. S. Skotnikov, V. L. Yun   +2 more
doaj   +1 more source

MONO- OR COMBINED ANTIHYPERTENSIVE THERAPY IN WOMEN WITH ARTERIAL HYPERTENSION AND MODERATE RISK OF CARDIOVASCULAR DISEASES: WHAT’S BETTER?

Медицинский совет, 2018
The study included 75 women with arterial hypertension, aged 48-51 years (Me 50,0 years [25%; 75%: 48,0; 52,0 years]), who according to the clinical laboratory and instrumental examination was diagnosed essential hypertension (EH) I–II stage of 1–2 ...
R. I. Stryuk, Y. V. Brytkova, O. V. Tatarinova   +2 more
doaj   +1 more source

Advances in radiopharmaceuticals for cancer radiotheranostics: CCK2R targeting as a paradigm for translational innovation

Cancer Communications, Volume 45, Issue 11, Page 1431-1455, November 2025.
Abstract Radiopharmaceuticals are reshaping the landscape of cancer therapy, offering a unique theranostic advantage that is becoming increasingly central to precision medicine. By labeling the same molecular scaffold with different radionuclides, these agents enable seamless integration of diagnostic imaging and targeted therapy.
Jing Li, Xuejun Wen, Rebeka Rita Reszegi, Hemavarshini Kamalrhaj, Wolfgang J. Parak, Xiaoyuan Chen, Jingjing Zhang   +6 more
wiley   +1 more source

Markers of diabetic nephropathy in patients with arterial hypertension III stage and type 2 diabetes mellitus and their correction [PDF]

, 2017
Метою нашої роботи було дослідження маркерів діабетичної нефропатії у пацієнтів із артеріальною гіпертензією та цукровим діабетом 2 типу та порівняння нефропротекторних властивостей антигіпертензивних препаратів для відбіру найоптимальнішого.
Chernatska, Olha Mykolaivna, Demikhova, Nadiia Volodymyrivna, Голубовська, Ф.Б., Демихова, Надежда Владимировна, Деміхова, Надія Володимирівна, Удовиченко, С.Я., Чернацкая, Ольга Николаевна, Чернацька, Ольга Миколаївна   +7 more
core  

Synergistic effects of Lespedeza and artichoke extracts in the therapy of chronic kidney disease: mechanisms and perspectives

Počki
Chronic kidney disease (CKD) is a major global health issue associated with oxidative stress, inflammation, and fibrosis. Traditional pharmacological approaches have limitations due to side effects and insufficient efficacy in the late stages of the ...
Z.O. Serebrovska, D.О. Tolstun, N.V. Sykalo, I.O. Farkhidinov, V. Kropyva, S.A. Myhovan, V.P. Chizhova, T.I. Kovtonyuk, I.A. Samots, B.M. Mankovsky   +9 more
doaj   +1 more source

Nephroprotective strategy in the treatment of hypertension as a modern general medical problem

Российский кардиологический журнал, 2018
The current population is characterized by a high prevalence of risk factors for the development of chronic kidney disease: hypertension, diabetes, obesity, metabolic syndrome, physical inactivity, smoking.
V. I. Podzolkov, A. E. Bragina, T. I. Ishina, L. V. Bragina, L. V. Vasilyeva   +4 more
doaj   +1 more source